Somatostatin Analog [EPC]

6873 reported adverse events

Drugs of this class: OCTREOTIDE PASIREOTIDE

These side effects are most commonly reported by patients taking drugs of the Somatostatin Analog [EPC] class:

# Side effect Count
0 OFF LABEL USE 856
1 DRUG INEFFECTIVE 826
2 DIARRHOEA 663
3 NAUSEA 532
4 FATIGUE 450
5 DEATH 422
6 VOMITING 302
7 ABDOMINAL PAIN 284
8 MALIGNANT NEOPLASM PROGRESSION 268
9 HEADACHE 250
See all common reactions for Somatostatin Analog [EPC]

Drugs of the Somatostatin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARCINOID CRISIS 60 0.2655
1 CARCINOID SYNDROME 36 0.0994
2 PANCREATIC NEUROENDOCRINE TUMOUR 45 0.0702
3 BLOOD CHROMOGRANIN A INCREASED 21 0.0458
4 BLOOD GROWTH HORMONE INCREASED 25 0.0448
5 CORTISOL INCREASED 27 0.0432
6 INSULIN-LIKE GROWTH FACTOR INCREASED 38 0.0266
7 NEUROENDOCRINE TUMOUR 37 0.0261
8 NECROTISING COLITIS 24 0.0189
9 PITUITARY TUMOUR 20 0.0134
See all enriched reactions for Somatostatin Analog [EPC]